UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 550

Sortiert nach

Inactivating NF1 Mutations Are Enriched in Advanced Breast Cancer and Contribute to Endocrine Therapy Resistance

Clinical cancer research, 2020-02, Vol.26 (3), p.608-622

2020

Volltextzugriff (PDF)

Specific JAK2 mutation (JAK2R683) and multiple gene deletions in Down syndrome acute lymphoblastic leukemia

Blood, 2009-01, Vol.113 (3), p.646-648

2009

Volltextzugriff (PDF)

Multicenter Randomized Phase II Clinical Trial Comparing Neoadjuvant Oxaliplatin, Capecitabine, and Preoperative Radiotherapy With or Without Cetuximab Followed by Total Mesorectal Excision in Patients With High-Risk Rectal Cancer (EXPERT-C)

Journal of clinical oncology, 2012-05, Vol.30 (14), p.1620-1627

2012

Volltextzugriff (PDF)

Next-generation sequencing: a change of paradigm in molecular diagnostic validation

The Journal of pathology, 2014-09, Vol.234 (1), p.5-10

2014

Volltextzugriff (PDF)

The clinical significance of NOTCH1 and SF3B1 mutations in the UK LRF CLL4 trial

Blood, 2013-01, Vol.121 (3), p.468-475

2013

Volltextzugriff (PDF)

Genetics and Prognostication in Splenic Marginal Zone Lymphoma: Revelations from Deep Sequencing

Clinical cancer research, 2015-09, Vol.21 (18), p.4174-4183

2015

Volltextzugriff (PDF)

Genomic landscape of platinum resistant and sensitive testicular cancers

Nature communications, 2020-05, Vol.11 (1), p.2189-2189, Article 2189

2020

Volltextzugriff (PDF)

Investigating the potential clinical benefit of Selumetinib in resensitising advanced iodine refractory differentiated thyroid cancer to radioiodine therapy (SEL-I-METRY): protocol for a multicentre UK single arm phase II trial

BMC cancer, 2019-06, Vol.19 (1), p.582-10, Article 582

2019

Volltextzugriff (PDF)

KRAS and BRAF mutations in circulating tumour DNA from locally advanced rectal cancer

Scientific reports, 2018-01, Vol.8 (1), p.1445-9, Article 1445

2018

Volltextzugriff (PDF)

Multi-purpose utility of circulating plasma DNA testing in patients with advanced cancers

PloS one, 2012-11, Vol.7 (11), p.e47020-e47020

2012

Volltextzugriff (PDF)

Treatment and Survival Outcome of BRAF-Mutated Metastatic Colorectal Cancer: A Retrospective Matched Case-Control Study

Clinical colorectal cancer, 2018-03, Vol.17 (1), p.e69-e76

2018

Volltextzugriff (PDF)

EuroClonality-NGS Recommendations for Evaluation of B-Cell Clonality Analysis by Next-Generation Sequencing: A Structured Approach with the DEPART Algorithm

The Journal of molecular diagnostics : JMD, 2023-10, Vol.25 (10), p.729-739

2023

Volltextzugriff (PDF)

Efficient Genotyping of KRAS Mutant Non-Small Cell Lung Cancer Using a Multiplexed Droplet Digital PCR Approach

PloS one, 2015-09, Vol.10 (9), p.e0139074-e0139074

2015

Volltextzugriff (PDF)

A Validation Study for the Use of ROS1 Immunohistochemical Staining in Screening for ROS1 Translocations in Lung Cancer

Journal of thoracic oncology, 2016-07, Vol.11 (7), p.1029-1039

2016

Volltextzugriff (PDF)

XBP1s levels are implicated in the biology and outcome of myeloma mediating different clinical outcomes to thalidomide-based treatments

Blood, 2010-07, Vol.116 (2), p.250-253

2010

Volltextzugriff (PDF)

Rare disruptive mutations in ciliary function genes contribute to testicular cancer susceptibility

Nature communications, 2016-12, Vol.7 (1), p.13840-13840, Article 13840

2016

Volltextzugriff (PDF)

FGF7–FGFR2 autocrine signaling increases growth and chemoresistance of fusion‐positive rhabdomyosarcomas

Molecular oncology, 2022-03, Vol.16 (6), p.1272-1289

2022

Volltextzugriff (PDF)

Comparison of testing methods for the detection of BRAF V600E mutations in malignant melanoma: pre-approval validation study of the companion diagnostic test for vemurafenib

PloS one, 2013-01, Vol.8 (1), p.e53733-e53733

2013

Volltextzugriff (PDF)

The genomic landscape of oesophagogastric junctional adenocarcinoma

The Journal of pathology, 2013-11, Vol.231 (3), p.301-310

2013

Volltextzugriff (PDF)

Challenges in molecular testing in non-small-cell lung cancer patients with advanced disease

The Lancet (British edition), 2016-09, Vol.388 (10048), p.1002-1011

2016

Volltextzugriff (PDF)

Analysis of KRAS, NRAS, BRAF, PIK3CA and TP53 mutations in a large prospective series of locally advanced rectal cancer patients

International journal of cancer, 2020-01, Vol.146 (1), p.94-102

2020

Volltextzugriff (PDF)

Establishing an EGFR mutation screening service for non-small cell lung cancer – Sample quality criteria and candidate histological predictors

European journal of cancer (1990), 2012-01, Vol.48 (1), p.61-67

2012

Volltextzugriff (PDF)

Ultra-Sensitive Mutation Detection and Genome-Wide DNA Copy Number Reconstruction by Error-Corrected Circulating Tumor DNA Sequencing

Clinical chemistry (Baltimore, Md.), 2018-11, Vol.64 (11), p.1626-1635

2018

Volltextzugriff (PDF)

The impact of SAMHD1 expression and mutation status in mantle cell lymphoma: An analysis of the MCL Younger and Elderly trial

International journal of cancer, 2021-01, Vol.148 (1), p.150-160

2021

Volltextzugriff (PDF)

Detection of EGFR Variants in Plasma: A Multilaboratory Comparison of a Real-Time PCR EGFR Mutation Test in Europe

The Journal of molecular diagnostics : JMD, 2018-07, Vol.20 (4), p.483-494

2018

Volltextzugriff (PDF)

1 – 25 von 550

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(479)
Mit Volltextzugriff
(514)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

2 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

Menü

Weitere Dienste

Einstellungen

Inactivating NF1 Mutations Are Enriched in Advanced Breast Cancer and Contribute to Endocrine Therapy Resistance

Specific JAK2 mutation (JAK2R683) and multiple gene deletions in Down syndrome acute lymphoblastic leukemia

Multicenter Randomized Phase II Clinical Trial Comparing Neoadjuvant Oxaliplatin, Capecitabine, and Preoperative Radiotherapy With or Without Cetuximab Followed by Total Mesorectal Excision in Patients With High-Risk Rectal Cancer (EXPERT-C)

Next-generation sequencing: a change of paradigm in molecular diagnostic validation

The clinical significance of NOTCH1 and SF3B1 mutations in the UK LRF CLL4 trial

Genetics and Prognostication in Splenic Marginal Zone Lymphoma: Revelations from Deep Sequencing

Genomic landscape of platinum resistant and sensitive testicular cancers

Investigating the potential clinical benefit of Selumetinib in resensitising advanced iodine refractory differentiated thyroid cancer to radioiodine therapy (SEL-I-METRY): protocol for a multicentre UK single arm phase II trial

KRAS and BRAF mutations in circulating tumour DNA from locally advanced rectal cancer

Multi-purpose utility of circulating plasma DNA testing in patients with advanced cancers

Treatment and Survival Outcome of BRAF-Mutated Metastatic Colorectal Cancer: A Retrospective Matched Case-Control Study

EuroClonality-NGS Recommendations for Evaluation of B-Cell Clonality Analysis by Next-Generation Sequencing: A Structured Approach with the DEPART Algorithm

Efficient Genotyping of KRAS Mutant Non-Small Cell Lung Cancer Using a Multiplexed Droplet Digital PCR Approach

A Validation Study for the Use of ROS1 Immunohistochemical Staining in Screening for ROS1 Translocations in Lung Cancer

XBP1s levels are implicated in the biology and outcome of myeloma mediating different clinical outcomes to thalidomide-based treatments

Rare disruptive mutations in ciliary function genes contribute to testicular cancer susceptibility

FGF7–FGFR2 autocrine signaling increases growth and chemoresistance of fusion‐positive rhabdomyosarcomas

Comparison of testing methods for the detection of BRAF V600E mutations in malignant melanoma: pre-approval validation study of the companion diagnostic test for vemurafenib

The genomic landscape of oesophagogastric junctional adenocarcinoma

Challenges in molecular testing in non-small-cell lung cancer patients with advanced disease

Analysis of KRAS, NRAS, BRAF, PIK3CA and TP53 mutations in a large prospective series of locally advanced rectal cancer patients

Establishing an EGFR mutation screening service for non-small cell lung cancer – Sample quality criteria and candidate histological predictors

Ultra-Sensitive Mutation Detection and Genome-Wide DNA Copy Number Reconstruction by Error-Corrected Circulating Tumor DNA Sequencing

The impact of SAMHD1 expression and mutation status in mantle cell lymphoma: An analysis of the MCL Younger and Elderly trial

Detection of EGFR Variants in Plasma: A Multilaboratory Comparison of a Real-Time PCR EGFR Mutation Test in Europe

Suchergebnisse filtern